MEDLEY (FRA:3YV) Ending Cash Position: €0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3YV MEDLEY Inc FRA:3YV
76 GF Score
Price €11.50
GF Value €37.13
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is MEDLEY Ending Cash Position?

MEDLEY FRA:3YV 76 Ending Cash Position is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:3YV with a GF Score™ of 76/100 and a GF Value™ of €37.13 (Significantly Undervalued). The stock has 3 warning signs investors should review.

MEDLEY's Ending Cash Position for the quarter that ended in Dec. 2025 was €0.0 Mil.

MEDLEY's annual Ending Cash Position increased from Dec. 2023 (€97.8 Mil) to Dec. 2024 (€117.9 Mil) but then declined from Dec. 2024 (€117.9 Mil) to Dec. 2025 (€47.0 Mil).

MEDLEY Ending Cash Position Related Terms

MEDLEY Ending Cash Position Historical Data

* Premium members only.

The historical data trend for MEDLEY's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDLEY Ending Cash Position Chart

MEDLEY Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 108.98 100.41 97.77 117.92 46.97

MEDLEY Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:3YV
76GF Score
MEDLEY Inc FRA:3YV
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MEDLEY Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

MEDLEY's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=104.026+-57.058
=47.0

MEDLEY's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.0

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €0.0 Mil mean?
MEDLEY (FRA:3YV) has a Ending Cash Position of €0.0 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on MEDLEY and its competitors.
Is MEDLEY's Ending Cash Position too high?
MEDLEY's current Ending Cash Position is €0.0 Mil. Overall, MEDLEY has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDLEY's Ending Cash Position compare to VEEV and BTSG?
MEDLEY's Ending Cash Position of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on MEDLEY and its competitors. MEDLEY's current Ending Cash Position is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDLEY stock overvalued right now?
Based on GuruFocus' analysis, MEDLEY (FRA:3YV) is currently considered Significantly Undervalued. The stock's GF Value™ is €37.13, compared to a current price of €11.50 — trading 69% below its estimated fair value. The current Ending Cash Position is €0.0 Mil. MEDLEY's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For MEDLEY (FRA:3YV), the current Ending Cash Position is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDLEY (FRA:3YV) Overvalued in 2026?

Based on GuruFocus' analysis, MEDLEY stock appears to be undervalued. The current stock price of €11.50 is trading 69% below its estimated GF Value™ of €37.13. GuruFocus considers MEDLEY to be Significantly Undervalued.

Key valuation signals for FRA:3YV:

  • Ending Cash Position: €0.0 Mil
  • GF Value™: €37.13 vs. price of €11.50 (69% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the FRA:3YV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MEDLEY Business Description

Other Exchanges MDLYF:USA4480:Japan
Address 3-2-1 Roppongi, Minato-ku, 22nd Floor Sumitomo Fudosan Roppongi Grand Tower, Tokyo, JPN, 106-6222
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.
76GF Score

Get the complete analysis for FRA:3YV

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.50
Price
€37.13
GF Value